Conformational changes in quadruplex oligonucleotide structures probed by Raman spectroscopy by Pagba, Cynthia V. et al.
Conformational changes in quadruplex 
oligonucleotide structures probed by  
Raman spectroscopy 
Cynthia V. Pagba,
1 Stephen M. Lane,
1, 2 and Sebastian Wachsmann-Hogiu
1,3,* 
1Center for Biophotonics Science and Technology, University of California Davis, 2700 Stockton Blvd., Suite 1400, 
Sacramento, CA 95817 
2Department of Neurological Surgery, University of California Davis, 4860 Y Street, Sacramento, CA 95817 
3Department of Pathology and Internal Medicine, University of California Davis, 4400 V Street, Sacramento,  
CA 95817 
*swachsmann@ucdavis.edu 
Abstract:  Quadruplex structures are higher order structures formed by 
guanine-rich oligonucleotides. In the present study, temperature-induced 
conformational changes in the quadruplex structures of aptamers and other 
guanine-rich oligonucleotides are probed by Raman spectroscopy. In 
particular, dramatic changes in the fingerprint region are observed in the 
spectra of thrombin binding aptamer at higher temperatures. These changes 
are accompanied by a decrease in the intensity of the 1480 cm
−1  peak 
(attributed to C8 = N7-H2), which is diagnostic of the quadruplex structure. 
We also show that these changes can be reversed (to a certain extent) by 
addition of K
+ ions. 
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1. Introduction 
Quadruplex (or tetraplex) structures are formed by guanine-rich DNA or RNA residues either 
by intramolecular folding (foldback) of a single strand (monomer), or by intermolecular 
association of two hairpin loops (dimer) or four molecules (tetramer) via Hoogsten-type 
guanine-guanine interactions (Fig. 1, scheme 1a). 
 
Fig. 1. Scheme 1a, Guanine quartet (tetrad) formed via Hoogsten-type H-bonding of four 
guanine molecules, with characteristic vibrational band frequencies. Scheme 1b, Chair (left) 
and basket (right)  intramolecular quadruplex structures consisting of 2 stacks of guanine 
quartets. Chair type is formed by lateral or edge looping while diagonal looping forms basket 
type. 
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on each other (Fig. 1,  scheme 1b). The formation of this structure is dependent on 






2+ among others. They can be classified as parallel or anti-parallel, 
depending on the orientation of the strands and the conformation of the guanosine residues. In 
parallel structure, all guanosines have anti  conformation, whereas in the antiparallel 
configuration, guanosine residues alternate between syn and anti (Fig. 1, scheme 1a). 
These structures were first found in telomeres, which play an important part in apoptosis. 
It was also found that these structures bind to telomerase (which is active in ~80% of cancer 
cells), leading to inhibition of its activity. Thus, there has been an active search for 
quadruplex-stabilizing ligands for cancer therapy. Quadruplex structures are also found in 
several proto-oncogenes such as, c-Myc, Bcl2, c-kit, VEGF [1,2] making them a potential 
molecular target of anti-cancer cancer drugs. 
Several aptamers, which are functional oligonucleotides (DNA, RNA and PNA), have 
also been reported to form such structures in the presence of their corresponding target 
molecules. Aptamers are generated by the process called Systematic Evolution of Ligands by 
Exponential Enrichment (SELEX) [3,4]. They have been shown to exhibit protein-binding 
affinities that are comparable to those of corresponding antibodies. This affinity results from 
the ability of the aptamers to form secondary structures such as hairpin loop, T-junction and 
quadruplex [5,6]. In particular, aptamers for certain cancer biomarkers [7–10], HIV-1 
associated proteins and thrombin [11] have been shown to form quadruplex structures. 
The formation of this structure can be detected by NMR spectroscopy [12–15], X-ray 
crystallography [16], circular dichroism spectroscopy [17,18], mass spectrometry [19–21], 
UV [22], infrared [23,24] and Raman spectroscopy [25–29]. Vibrational spectroscopy is a 
valuable tool in studying the secondary structures of nucleic acids, as it is sensitive to their 
different conformations. This is due to the fact that changes in the conformation often lead to 
changes in the vibrational frequencies of the sugar-phosphate backbone and nucleic acid 
vibrations [30–32]. 
In the present study, Raman spectra of the quadruplex-forming thrombin binding aptamer 
(TBA) are recorded at different temperatures both in the presence and absence of potassium 
ions. We show that the quadrudplex structure of TBA is lost at higher temperatures but is 
restored in the presence of stabilizing K
+  ions. Raman spectra of other guanine-rich 
biologically important DNA sequences (HIV integrase aptamer, T30695; Human Telomeric 
Sequence 1 and Sequence 2, HT1 and HT2, respectively; Bcl-2  promoter sequence; and 
d(G2T4G2CAG2GT4G2T) that are capable of forming intramolecular quadruplex structures are 
also recorded. Our results show that drop coating deposition Raman spectroscopy could be 
used for analysis of guanine-rich DNA sequences to detect the formation of and the 
conformational changes in the quadruplex structures. The present study uses less concentrated 
(micromolar range) DNA solutions than what is normally required (millimolar range) for 
Raman measurements of biological solutions (e.g. refs 25-27), and is an extension of our 
previous work which presented Raman and SERS spectra of thiolated and unthiolated TBA 
(29). 
2. Materials and methods 
2.1. Reagents 
Potassium chloride and Hyclone water were obtained from Fisher Scientific. All the 
oligonucleotides were ordered from Sigma Chemical Company and used without further 
purification. The DNA sequences of the oligonucleotides used are listed in Table 1. 
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   DNA Sequence  Name 
a  5′-GGTTTTGGCAGGGTTTTGGT-3′  DDCRDL 
b  5′-(TTAGGG)4-3′ 
 
Human Telomeric Sequence  1 (24 nt) 
c  5′-[AGGG(TTAGGG)3]-3′  Human Telomeric Sequence 2 (22 nt) 
d  5′-GGGCGCGGGAGGAATTGGGCGGG-3′  Bcl-2 promoter sequence 
e  5′-GGGTGGGTGGGTGGGT-3′ 
 
HIV-1 Integrase aptamer (T30695) 
f  5′-GGTTGGTGTGGTTGG-3′ 
 
Thrombin Binding Aptamer (TBA) 
2.2. Glass substrate pretreatment 
Fused silica cover slips were cleaned by sequential sonication in 1M NaOH, Milli Q water, 
1M HCl, water, and acetone for 15 minutes each. They were further rinsed with Milli Q water 
three times and dried under nitrogen flow. 
2.3. Raman measurements 
Spontaneous Stokes Raman spectra were recorded using the drop coating deposition Raman 
(DCDR) method [33–35], a technique that takes advantage of the so-called coffee ring effect, 
that is, the tendency of the dissolved substrate to deposit on the rim of the ring formed upon 
drying of the solution. Briefly, 20 µL of a 10 µM oligonucleotide (in pure water or 100 mM 
KCl) was deposited on fused silica with non-adhesive silicone isolator (Grace Bio-Labs, Bend 
OR), to ensure uniformity of the size of the drop for all the samples, and allowed to dry either 
at 4°C, 25°C, 60°C or 90°C. The silicone isolator was carefully removed before measurement. 
Before deposition, samples were incubated at 4°C and 25°C for at least 1 hour and at 60 and 
90°C for about 10 minutes. Raman spectra were acquired using a custom-built Raman system 
with a 60x water objective, 1.32 NA and 785 nm CrystaLaser excitation wavelength. A 
SpectraPro 2300i Acton spectrometer with a Princeton Instruments Pixis100 back-illuminated 
deep-depletion CCD was used for dispersing and recording the spectra. An integration time of 
180 s, and laser power of approximately 10 mW were used for all spontaneous Raman 
measurements. The plotted spectra were obtained by taking an average of five measurements 
from five different spots in the rim of the drop. A non-parametric baseline correction was 
performed on all spectra using the PeakFit software. In addition, the background of the fused 
silica coverslip was measured outside the ring and subtracted in all Raman measurements. 
3. Results and discussion 
3.1. Thrombin binding aptamer (TBA) 
Figure 2 (top) shows individual traces obtained from five different spots in the rim of the drop 
of the TBA sample incubated at 4°C, demonstrating the homogeneity of the sample. Figure 2 
(bottom) presents the Raman spectra of TBA incubated at different temperatures (4°C, 25°C, 
60°C and 90°C). Several changes in the spectra of the TBA are observed as the temperature is 
increased (Fig. 2 bottom, Table 2). These spectral changes are discussed by specific TBA 
components. 
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Fig. 2. Top: raw Raman spectra of TBA incubated at 4°C and measured from five different 
spots in the rim of the drop. Bottom: Temperature dependent TBA Raman spectra. (a) 4°C, (b) 
25°C, (c) 60°C, (d) 90°C. The spectra are normalized with respect to the most intense for each 
trace. 
3.1.1. Guanine tetrad (H-bond formation) 
The vibrational band around 1480 cm
−1 is assigned to the C8 = N7-H2 bond deformation of 
the guanine tetrad and is therefore a marker for the presence of the quadruplex structure 
[25,26]. It can be seen from Fig. 2  that the intensity of this band is reduced at higher 
temperatures, c indicating the loss of hydrogen bonding between N7 and H2 of the guanine 
residues due to the loss of the quadruplex structure. This observation is supported by the 
accompanying increase in the intensity of the Raman peak around 1670 cm
−1, corresponding 
to the C6 = O6 stretching mode of guanine [23,25,26]. This is due to the loss of the H-bond 
between O6 and H1.). In addition, there is an increase in the 1050 cm
−1  peak, initially 
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−1 band, which is attributed to C = O deformation mode 
[31], again indicating loss of hydrogen bonding. 
Table 2. Raman Frequencies of Thrombin Binding Aptamer Incubated at Different 
Temperatures 
 Frequency, cm
−1     
4°C  25°C  60°C
a  90°C
a  Assignment
b  References 





    dG, C2′ endo/syn   [25,28] 
685  685      dG C2′ endo/anti   [25,37] 
748  748      Thymine, OPO anti-sym str   [31] 
777  777      dT, C3′ endo/anti   [27] 
785  785      OPO sym str   [28,30,31] 
837  837      OPO gauche
-/gauche
- conformation   [38] 
840  840      Sugar vib (C2′ endo)   [37] 
860  860      Sugar vib (C3′ endo)   [37] 
    885  885  Sugar vib (C3′endo)   
    998  998     
    1005  1005  deoxyribose vib   [31] 










    PO2
- sym str in the TGT loop of 
HS-TBA 
 [23] 
1095  1095      PO2
- sym str   [23,25,37] 
      1102  OPO   
    1120  1120  Sugar vib   [32] 
1180  1180      dT   [28] 
1245  1245      dT, N-H def and C-N str of 
Guanine 
 [28] 
    1278  1278  G-ring str, C-H def of Thymine   [32,39] 
1325  1325      dG, C2′ endo/syn   [25] 
1333  1333      dG, C2′ endo/anti   [25] 
1370  1370      dT, dG C2′ endo/syn   [28] 
1376  1376      dT   [36] 
1425  1425      deoxyribosyl (C5′H2) def   [28,30,31] 
    1434  1434  deoxyribosyl (C5′H2) def   [28,31] 
1480  1480      C8 = N7-H2 def   [25,32,38] 
1570  1570      C2 = N3 of Guanine   [23] 
1580  1580      dG   [23,28] 
1603  1603      N1-H in plane bending   [25] 
1670  1670      C6 = O6 of Guanine   [23] 
a For clarity, only the additional peaks are listed. 
bAbbreviations: dG, deoxyguanosine; dT, deoxythymidine; OPO, phophodiester backbone; PO2
-, ionized phosphate 
backbone; def, deformation; str, stretching; vib, vibration; sym, symmetric; s, strong; m, moderate; w, weak; vw, very 
weak; sh, shoulder. 
3.1.2. Nucleoside (sugar-base) conformation 
The guanine breathing mode, normally found at 650 cm
−1, is sensitive to its environment. In 
guanosine, its value ranges from 600 to 700 cm
−1 depending on the sugar-base conformation. 
For example, in B-DNA, this vibrational mode is found at ~682 cm
−1, which is diagnostic of 
C2′-endo/anti  deoxyguanosine (dG) sugar conformation [25,31,32]. The same guanosine 
conformation is found in parallel quadruplex structures [25]. In an anti-parallel quadruplex, 
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corresponding to the C2′-endo/syn conformation is also found [25]. TBA, which assumes an 
antiparallel topology exhibits a strong band at around 682 cm
−1, indicating C2′-endo/anti 
guanosine conformation. The band corresponding to C2′-endo/syn conformation around 670 
cm,
−1 which should also be expected in an anti-parallel quadruplex is only seen as a shoulder 
to the much stronger 682 cm
−1 band. The presence of C2′-endo/syn conformation, however, is 
indicated by the intense 1370 cm
−1 band (also attributed to deoxythymidine, dT) and by the 
1324 cm
−1 shoulder to the 1336 cm
−1 band due to C2′-endo/anti conformation [25,26,28]. 
As the temperature is raised, several changes in these regions (600-700 cm
−1 and 1300-
1400 cm
−1) are observed. The band around 680 cm
−1 disappears and a new band at 630 cm
−1 
emerges, suggesting a change from a C2′-endo/anti to C3′ -endo/syn conformation [32,36]. 
These changes are accompanied by a decrease in the 1370 cm
−1 band and the disappearance 
of 1324 cm
−1 and 1333 cm
−1 peaks suggesting the loss of dG anti and syn conformation, 
respectively. These observations are further supported by the accompanying shift of 840 cm
−1 
band, due to C2′-endo sugar conformation, to 885 cm
−1 band that is characteristic of C3′-endo 
sugar conformation [37]. The shift of 1422 cm
−1 band, assigned to C5′H2 deformation in C2′- 
endo sugar conformation [28,30,31], to 1434 cm
−1 band is also consistent with the loss of the 
C2′ -endo conformation. 
It can also be seen that the intensities of the 1580 cm
−1 and 1018 cm
−1 bands both assigned 
to deoxyguanosine (dG) are greatly reduced at higher temperature suggesting that these bands 
are associated with the quadruplex form. In addition, the band around 1180 cm
−1, which is 
due to deoxythymidine (dT), disappears. The disappearance of this band at higher temperature 
strongly indicates that this dT vibrational mode is associated with the quadruplex structure. A 
new band around 1280 cm
−1, which corresponds to C-H deformation in thymine [32,39], 
starts to appear at 60°C. 
3.1.3. Phosphate backbone 
The intense 1095 cm
−1 band, which corresponds to the symmetric stretching of the ionized 
phosphate (PO2
-) groups in the guanine nucleotides involved in the Hoogsten-base pairing 
[23] are indicative of the presence of the guanine tetrad. As the temperature is increased, the 
intensity of this band is reduced and is shifted to a less intense band at around 1100 cm
−1, 
suggesting a change in phosphate backbone due to melting. This observation is supported by 
a dramatic decrease in the intensity of 745 cm
−1 band (due to phosphodiester anti-symmetric 
stretching) with accompanying increase in intensity of 785 cm
−1 band (due to phosphodiester 
symmetric stretching). 
3.1.4. Stabilization by K
+ ions 
Figure 3 presents the spectra of TBA with and without KCl. The spectra obtained at 25°C 
(Fig. 3, top) both show the characteristic bands of a quadruplex structure but there are minor 
differences observed. Most notably, the C6 = O6 band (~1670 cm
−1) in the spectrum of TBA 
with K
+ is less intense relative to that of the 1580 cm
−1 band. This reduction in intensity can 
be attributed to the interaction (i.e., coordination-bond formation) of the K
+ ion with the H-
bonded O6. The diagnostic 1480 cm
−1 band is also more intense compared to the 1425 cm
−1 
peak. These observations point to the added stability of the quadruplex structure provided by 
the K
+ ions. 
It can also be seen that the addition of K
+ ions restores the quadruplex structure of TBA 
incubated 60°C (Fig. 3  middle, a), as evidenced by the presence of the characteristic 
quadruplex peaks such as, 685, 850, 1090, 1327, 1333, and 1480 cm
−1. In addition, the 1580 
cm
−1 peak becomes more intense compared to that of TBA in water alone, further supporting 
the presence of the quadruplex structure at 60°C. However, no stabilization is observed at a 
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(melting) temperature of TBA (~50°C) [17]. 
 
Fig. 3. Quadruplex Stabilization by K
+. Top: Raman spectra of TBA incubated at 25°C without 
(a) and with (b) 100 mM KCl. Middle: Raman spectra of TBA incubated at 60°C without (a) 
and with (b) 100 mM KCl. Bottom: Raman spectra of TBA incubated at 90°C without (a) and 
with (b) 100 mM KCl. The spectra are normalized with respect to the most intense peak for 
each trace. 
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It has been reported that there about 26 different topologies (folds) for molecules that 
comprise three loops with contiguous G-quartet strands [40]. It is interesting to determine if 
Raman spectroscopy can distinguish these different folds. Figure 4  presents the Raman 
spectra of selected guanine-rich oligonucleotides with known different quadruplex topologies 
(folds), namely: the all ‘parallel’ double chain reversal loops [HT1 and HT2]; lateral, lateral, 
double chain reversal loops [Bcl-2 promoter sequence, 
d(GGGCGCGGGAGGAATTGGGCGGG)] [41]; diagonal, double chain reversal, diagonal 
loops (DDCRDL) [d(GGTTTTGGCAGGGTTTTGGT)] [42]; and all lateral loops [Thrombin 
Binding Aptamer, TBA [15] and HIV-1 Integrase aptamer, T30695 [43]]. 
 
Fig. 4. Raman spectra of oligonucleotides incubated at 4°C. (a) DDCRDL Aptamer, (b) 
Human Telomeric Sequence 1 (24 nt), (c) Human Telomeric Sequence 2 (22 nt), (d) Bcl-2 
promoter sequence, (e) HIV integrase aptamer (T30695), and (f) Thrombin Binding Aptamer 
(TBA). The spectra are normalized with respect to the most intense peak for each trace. 
It can be observed that all the DNA sequences we studied exhibit the 1480 cm
−1 band (due 
to C8 = N7-H2) that is diagnostic of the quadruplex form as well the characteristic 682 cm
−1 
band due to the C2′-endo/anti deoxyguanosine (dG) sugar conformation, present in parallel 
strands. The dT band around 1180 cm
−1 and the phosphate backbone band at round 1090 are 
also found in all the spectra. While all the DNA sequences studied share common bands that 
are characteristic of the quadruplex form, they also show some noticeable differences, which 
may reflect their composition, their topologies, or both. For instance, the band around 610 
cm
−1, corresponding to C2′  -  endo/syn  deoxythymidine (dT) conformation [25,27], is 
moderately intense in the first four oligonucleotides but is absent in TBA and T30695, which 
assume similar fold. Since both TBA and T30695 aptamers also contain thymine residues, the 
absence of this band in their spectra may indicate that this band is topology sensitive. 
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−1  region. In T30695 
spectrum, the 1336 cm
−1 band, which corresponds to C2′ endo/anti dG conformation, is more 
prominent than 1327 cm
−1 peak (due to C2′ -endo/syn conformation). The 1327 cm
−1 band, 
which is diagnostic of the C2′ -endo/syn dG conformation is more intense in the spectrum of 
Bcl-2 promoter sequence, which reflects the higher guanine ratio. Similarly, the 1370 cm
−1 
peak, which corresponds to dT vibration, is much more intense in the DDCRDL 
oligonucleotide spectrum due to increased number of thymine residues in the aptamer. 
There are also significant differences observed in the 700-800 cm
−1 region. First, the 785 
cm
−1 band (assigned to the symmetric phosphodiester stretching and cytosine ring breathing 
mode) [30] is more intense in the Bcl-2 spectrum compared to the rest of the spectra, due to 
the presence of 3 cytosine residues in the sequence. Second, the 725 cm
−1 band (assigned to 
the adenine ring breathing vibration) [31] is moderately intense in the spectra of adenine-
containing oligonucleotide sequences, HT1, HT2 and Bcl-2 promoter but is only a shoulder in 
the spectrum of DDCRDL aptamer, as there is only one adenine residue in the sequence. 
Third, the 748 cm 
−1 band (assigned to the thymine ring breathing vibration) is observed in all 
the spectra except for that of Bcl-2 promoter sequence. These results may be showed that 
Raman spectroscopy may be explored to monitor the formation of as well as the stability of 
quadruplex structures. 
4. Conclusion 
We use Raman spectroscopy to show the formation of and stability of the TBA quadruplex 
structures at different temperatures. We show that at higher temperatures (≥ 60°C), TBA 
forms another structure that is dominated by a C3′- endo dG conformation, also found in A-
DNA [44]. We also demonstrated that potassium ions can stabilize the quadruplex form of 
TBA at temperatures close to its melting point as evidenced by the restoration of the Raman 
bands that are associated with the quadruplex structure. 
These results show that Raman spectroscopy may be used to monitor conformational 
changes in certain quadruplex structures. While this method provides low-level resolution, it 
provides sufficient information for verifying the presence of such structures, as well as their 
stability. It also offers the possibility of determining its topology (folding) and may also 
explored for routine diagnostic method of monitoring the conformational changes that a 
particular quadruplex topology undergoes in response to changes in its environment (e.g. 
ligand binding, metal binding, temperature change). We believe that the results will be 
particularly useful in initial structural studies of newly developed aptamers that are rich in 
guanine residues. 
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